文献速递腹部介入MR

钆塞酸二钠增强MRI监测门静脉栓塞及扩大半肝切除术后未来残肝功能的前瞻性试验

Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
PubMed 文献 · Eur Radiol · 2016-12-13

这项前瞻性试验对37例接受门静脉栓塞的患者,在栓塞前、栓塞后14天和28天及扩大右半肝切除后10天行钆塞酸二钠增强MRI,计算各叶体积、动力学增长率、相对强化、肝细胞摄取指数和脂肪信号分数。结果显示左肝叶相对强化在栓塞后持续升高,术后10天降至0.48±0.19,显著低于栓塞后14天和28天(P<0.05);肝细胞摄取指数在栓塞后14天和28天均显著高于栓塞前(P<0.05)。作者认为钆塞酸二钠增强MRI可能用于监测门静脉栓塞后未来残肝的功能性增长,并显示导致残肝功能下降的术中肝损伤。

要点

  • 未来残肝体积最显著的增长发生在门静脉栓塞后前14天内。
  • 没有任何MRI参数能够预测未来残肝增长的成功与否。
  • 作者数据提示可在门静脉栓塞后约14天行早期切除。

核心结论

  • 钆塞酸二钠增强MRI可能用于监测门静脉栓塞后未来残肝的功能性增长,并显示导致残肝功能下降的术中肝损伤。

研究设计与样本

  • 前瞻性试验纳入37例接受门静脉栓塞的患者,在栓塞前、栓塞后14天和28天及扩大半肝切除后10天行钆塞酸二钠增强MRI,计算各叶体积、动力学增长率、相对强化、肝细胞摄取指数和脂肪信号分数。

关键影像表现/征象

  • 左肝叶相对强化在门静脉栓塞后持续升高,术后10天降至0.48±0.19,显著低于栓塞后14天和28天(P<0.05)。
  • 左肝叶肝细胞摄取指数在门静脉栓塞后持续升高,栓塞后14天和28天均显著高于栓塞前(P<0.05)。
  • 术后残肝的肝细胞摄取指数低于术前。

诊断标准与关键数值

  • 门静脉栓塞至栓塞后14天期间的动力学增长率为14.06±9.82%/周。

临床应用与阅片要点

  • 作者建议可考虑在门静脉栓塞后约14天行早期切除。
  • 作者认为常规钆塞酸二钠增强MRI可能适合替代ICG试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate changes in liver function after right portal vein embolization (PVE) and extended right hemihepatectomy using gadolinium ethoxybenzyl-DTPA-enhanced (Gd-EOB-DTPA) MRI.

METHODS: In this prospective trial, 37 patients undergoing PVE were examined before and 14 and 28 days after PVE and 10 days after extended hemihepatectomy using Gd-EOB-DTPA-enhanced MRI. Lobar volume, kinetic growth rate (KGR), relative enhancement (RE) as well as hepatocellular uptake index (HUI) and fat signal fraction (FSF) were calculated for each lobe.

RESULTS: RE of the left liver lobe (LLL) was steadily increasing after PVE and decreased to 0.48 ± 0.19 10 days after surgery, which is significantly lower than 14 days and 28 days post PVE (P < 0.05). KGR was 14.06 ± 9.82%/week for the period from PVE to 14 days after PVE. HUI of the LLL increased steadily after PVE and was significantly higher at both 14 and 28 days after PVE compared to pre PVE (P < 0.05). HUI of the residual liver after surgery was lower than before.

CONCLUSIONS: Gd-EOB-DTPA-enhanced MRI may be used to monitor the functional increase in the FLR after PVE and to depict the intraoperative liver injury leading to a decrease in liver remnant function.

KEY POINTS: • The most significant FLR volume increase happens within the first 14 days. • No MRI parameter was able to predict the success of FLR growth. • Our data suggest an early resection about 14 days after PVE. • Routine Gd-EOB-DTPA-enhanced MRI might be suitable to replace ICG-test.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Geisel D, Raabe P, Lüdemann L, et al. Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial. Eur Radiol. 2016. PMID: 27966044. doi:10.1007/s00330-016-4674-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。